ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $98,000 | -89.6% | 36,500 | -88.5% | 0.00% | -92.9% |
| Q1 2019 | $939,000 | +120.4% | 317,095 | +18.5% | 0.01% | +100.0% |
| Q4 2018 | $426,000 | -49.9% | 267,613 | +15.8% | 0.01% | -41.7% |
| Q3 2018 | $850,000 | +40.5% | 231,113 | +8.1% | 0.01% | +20.0% |
| Q2 2018 | $605,000 | +7.7% | 213,813 | +41.2% | 0.01% | +11.1% |
| Q1 2018 | $562,000 | +25.2% | 151,400 | -2.9% | 0.01% | +12.5% |
| Q4 2017 | $449,000 | – | 155,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |